Abstract
284TiP CYCLONE 3: A phase III, randomized, double-blind, placebo-controlled study of abemaciclib in combination with abiraterone plus prednisone in men with high-risk metastatic hormone-sensitive prostate cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have